FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewThe significance of FOXP1 in diffuse large B-cell lymphoma.FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysisN-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding.Esophageal development and epithelial homeostasis.The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.MicroRNA profile for health risk assessment: Environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery.SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase functionThe autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.Rare and Common Variants Conferring Risk of Tooth Agenesis.
P2860
Q27304386-146A1FC5-3ED5-4A17-A808-84393463AE7EQ34047455-53E73554-8BFE-48C0-921F-E112254D786FQ36650112-F4F06DF9-1E72-4978-AE2D-A4356C4969E2Q37125561-F41438CA-ED09-4DA4-8BA1-6DDB9C89121EQ37216467-62BE1477-9B46-433B-88AE-3FD1ED5CF596Q37619689-13EF8BBC-1D33-4750-80F9-6B7DF1757C19Q37645070-7468BBC9-A943-41DD-852D-293F5B6F8378Q38542183-303BD3F2-A47C-43EF-9571-2D177C61218EQ38727975-09630043-3F43-4862-BDDA-204F1057EFAAQ39400127-B95082FC-EFA8-4A71-8D9E-A2E72469D9A4Q41504049-EA3775C6-9865-40A4-937C-DE0862EB6422Q42009353-219D2534-3D20-4FEE-8855-D57530F0FC06Q42510417-504E5310-DAC6-4015-BF58-805A0FA0ECB5Q47419522-9C59CA62-410D-4138-9247-01A707D661C2Q48174705-3023DABB-406E-4859-987D-11F019DA7D11
P2860
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
@ast
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
@en
type
label
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
@ast
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
@en
prefLabel
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
@ast
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
@en
P2093
P2860
P1433
P1476
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma
@en
P2093
Alex D Rabinowitz
Allison M Deal
Blossom Damania
Charles M Stopford
Christopher Jahn
David M Graham
Dennis Goldfarb
Ian J Davis
P2860
P356
10.1126/SCISIGNAL.2005654
P577
2015-02-03T00:00:00Z